A. Introduction
Multiple steps are involved in hematopoietic differentiation and maturation from multipotent progenitor cells to terminally differentiated cells of each lineage. The availability of recombinant growth factors and of various clonogenic precursor cell assays has provided useful information about hematopoietic precursors, notably of the myeloid lineage [1] [2] [3] . However, the direct evaluation of primitive human lymphohematopoietic progenitor cells has been hampered by their low frequency in normal donors and the difficulties involved in expanding them in in vitro culture [4, 5] . Therefore, little is known about the events and mechanisms that result in the irreversible commitment of multipotent uncommitted progenitors to a specific cell lineage. Leukemias have been traditionally used as a model for lymphohematopoietic development and have been studied extensively for the expression of differentia- 214 tion antigens [6, 7] and recently for rearrangements of genes of the immunoglobulin supergene family [8, 9] . They are considered to represent clonal expansions of lymphoid and myeloid progenitor cells and therefore provide an opportunity to study homogeneous populations of lymphohematopoietic progenitor cells. However, leukemic cell lines with the potential for multiline age differentiation that would allow the study of early events of lymphohematopoietic development are very rare [10, 11] . We report a novel acute lymphoblastic leukemia (ALL), MT-ALL, with a predominantly mature CD3 + TCR (Xlf3+ phenotype, which in response to various growth factors displays the potential for multilineage differentiation in vitro. This leukemia may be instrumental in elucidating mechanisms involved in early lymphohematopoietic development.
B. Materials and Methods
Leukemic cell cultures were set up as shown in Fig. 1 and as previously reported [12] . Southern analysis was performed according to standard methods [12, 13] . The genomic probe pb7 detects the constant region of the T-cell receptor (TCR) b gene (1M. Greenberg, C.w. Wilkowski, IH. Kersey, unpublished results). pTy1 is a cDNA probe derived from the leukemic cell line HPB-mlt [14] , kindly provided by R. Holcombe. The Tf3 probe is a cDNA probe kindly provided by T.W Mak. Methods for the lymphokine-activated (LAK) and natural killer (NK) cell assays as well as the oxygen production assay have been described elsewhere [15, 16] .
Clinical Course of the Patient. The 15-year-old caucasian male presented with hemorrhagic diathesis, hepatosplenomegaly, and mediastinal mass. White blood cell count was 759000/~1, containing 99% lymphoblasts, which were CD2+ TdT+ CD4-CDS-. Complete remission was achieved lasting for 5 months. The patient relapsed and attained unsustained remissions during which peripheral blood was obtained at three different times after informed consent. The patient died 1 year after diagnOSIS.
c. Results and Discussion
The leukemia presented in the patient with a predominantly mature T-Iymphocyte phenotype (CD2 + CD3 + CD4-CD5+ CD7+ CDS-TCRrt./f3+) and a morphology typical for lymphoblasts ( Fig. 2A ). In the presence of different recombinant growth factors, various leukemic cell lines belonging to different cell lineages were established (Fig. 1) . In the presence of interleukin 3 (lL-3) and/ or granulocyte-macrophage colony-stimulating factor (GM-CSF), myeloid and monocytoid cells grew out, including terminally differentiated neutrophilic granulocytes (Fig. 2B) . The cells were myeloperoxidase positive and expressed the myelomonocytic differentiation antigens CD13, CD14, MYS, and CD33 [17] , Fig. 1 . Fresh peripheral blood leukemic blasts were cultured in the presence of rh GM-CSF (10-50 V/ml), IL-3 (10 V/ml), IL-2 (100 V/ml), or no growth factor.
T + /-: positive/ negative staining for T -lineage associated antigens; M + / -: positive/negative staining for myeloid while they were devoid ofT-lineage associated antigens. The oxygen radical production, which is a typical feature of mature functional granulocytes, was assessed by measuring the reduction of the reporter substrate nitro blue tetrazolium (NBT) in the presence of various stimuli [16] . After stimulation with phorbol myristate (5 ng/ml), but not with the chemotactic oligopeptide F-met-Ieu-phe [16] , NBT was reduced, proving that the myeloid cells were at least partially functional (data not shown).
A growth factor independent (GFI) leukemic cell line was established from the IL-3 cultures. Morphologically, these were undifferentiated blasts (Fig. 2 C) , coexpressing T-Iymphoid (CD2, CD3, CD5, CD7, TCRrt./f3) and myeloid lineage (CD13, CD14, CD33) associated differentiation antigens. In functional studies (oxygen radical production and NK and LAK activity; Fig. 3 ) these cells were inactive.
In the presence of IL-2, a cell line consisting of large lymphocytes with azurophilic granules (Fig. 2 D) was established. In addition to the T-lineage associated antigens, the IL-2 dependent leukemic cells expressed CDS and Leu-19, which can be found on cytotoxic Tlymphocytes [1S, 19] . Functional studies confirmed that they represented the counterpart of MHC unrestricted cytotoxic T-Iymphocytes [19] . The IL-2 de- pendent leukemic cell cultures exerted high lytic activity against the NK sensitive target cell line K562 and the NK resistant cell line HL-60 [15] (Fig. 3) . Surprisingly, the IL-2 dependent cell line coexpressed CD33 (data not shown). Molecular genetic analysis demonstrated unambiguously that the various leukemic cell cultures were derived from the same malignant clone. Identical, unique rearrangements of the TCR [) (Fig. 4A, B) , y (Fig. 4C) , and P (Fig. 4D) genes were demonstrated by Southern analysis. The TCR [) gene rearrangement, detected with the TCR <> constant region probe p[)7, most likely represents a V [)3-J<>1 rearrangement [12, 13, 19, 20] . Southern analysis using various restriction enzymes and a J b1 probe were consistent with this interpretation (data not shown). Cytogenetic analysis (Table 1) revealed a three way translocation (1;10;12) (q25;p13;p13) and a deletion of (6q15;q25) in all cell cultures analyzed, consistent with the molecular genetic findings.
In conclusion, we have characterized a novel leukemia which gives rise to cells belonging to different cell lineages, notably T -lymphoid and myeloid. We concluded that the cell lines were presumably derived from a putative multipotent leukemic progenitor. However, the exact pathway of multilineage differentiation remains to be elucidated. One possibility is that a minor population of multipotent leukemic progenitor cells which was present in the peripheral blood blasts of the patient, but undetectable by fluorescence-activated cell sorter (FACS) analysis, differentiated in response to various growth factors into the respective lineages. Alternatively, minor populations oflineage committed cells might have acquired a growth advantage under the different culture conditions which resulted in outgrowth of the different cell cultures. A third hypothesis suggests that due to posttransformational alterations of the genetic program, the mature CD3+TCRo:/P+ T-Iymphoblasts were capable of undergoing lineage switch. (Fig. 4A, D) and Xba I (Fig. 4B, C) and hybridized with the genomic TCR fJ probe pfJ7 (Fig. 4 A, B) , the TCR y cDNA probe pTy1 (Fig. 4 C) and the TCR fi cDNA probe Tfi. eage instability" and underwent "lineage switch" to macrophages [22] . Whether similar mechanisms are operational in our novel leukemic cell line is currently under investigation. Further studies will specifically address possible mechanisms involved in the process of multilineage differentiation in this instructive leukemia. We hope that these studies will be useful for a better understanding of events of early lymphohematopoiesis, notably of the mechanisms that are involved in the irreversible commitment of multipotent progenitors to different cell lineages.
